ClinicalTrials.gg
RecruitingNCT07804927Updated Sep 4, 2026

STRess Assessment of INterventional Cardiology Fellows and Attendings

An observational study in Stress, sponsored by Minneapolis Heart Institute Foundation. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Minneapolis Heart Institute Foundation · Observational

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
15
Ages
18 Years and older
Sex
All
01

Study summary

Interventional cardiology (IC) fellows and attendings experience high levels of stress. In a recent study, IC fellowship was considered very stressful by 22%, somewhat stressful by 62%, and not stressful by 16%(1). In a different study, 29% of the IC fellows considered leaving their job during the past year, while more than a quarter (29%) felt overwhelmed ≥3x/week(2). Moreover, the same study reports that burnout affects 69% of the interventional cardiologists. In addition, in the Medscape Cardiologist Lifestyle, Happiness \& Burnout Report 2023, 43% of the cardiologists in general reported being burned out and 23% were depressed(3). However, it remains unknown whether they deal with increased stress before, during, and after a procedure, if their stress decreases (and if so, how much) with experience, and how they recover after a procedure. The present study will study the stress levels of IC fellows and attendings using various subjective metrics and wearable devices.

02

Conditions studied

  • Stress
03

In context

Lead sponsor

Minneapolis Heart Institute Foundation is the lead sponsor of 34 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The target study population is all interventional cardiology attendings and fellows at Minneapolis Heart Institute.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Interventional Cardiology fellow or attending.
  2. Age 18 years or older.
  3. Willing and able to provide .
  4. Access to smartphone (Apple or Android platform).
  5. Willing and able to wear the wearable devices.

Exclusion criteria

Exclusion Criteria:

1- Any health condition that in the opinion of the investigator would preclude individual's participation in the study such as conditions that would preclude them from wearing the study wearables and participating to provide wearable data.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
15 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Heart Rate Variability (HRV)

    Heart Rate Variability (HRV) as assessed by the wearable devices

    Time frame: From enrollment to end of study period at 14 days

Secondary outcomes

  1. Stress

    Subjective stress assessed by the STAI-short version at baseline, before and after a procedure. Higher scores on the STAI indicate greater anxiety

    Time frame: Baseline and at the end of study period at 14 days

  2. Procedural characteristics

    Procedural characteristics as assessed by the post-procedural questionnaire

    Time frame: Perioperative

  3. Burnout

    Burnout as assessed by the Mini-Z survey. A higher score indicates increased burnout

    Time frame: From enrollment to end of study period at 14 days

  4. Heart Rate

    Heart rate as assessed by the wearable device(s).

    Time frame: From enrollment to end of study period at 14 days

  5. Sleep

    Sleep metrics as assessed by the wearable device(s).

    Time frame: From enrollment to end of study period at 14 days

  6. Blood oxygen

    Blood oxygen as assessed by the wearable device(s).

    Time frame: From enrollment to end of study period at 14 days

  7. Respiratory rate

    Respiratory rate as assessed by the wearable device(s).

    Time frame: From enrollment to end of study period at 14 days

  8. Body temperature

    Body temperature as assessed by the wearable device(s).

    Time frame: From enrollment to end of study period at 14 days

  9. Workout metrics

    Workout metrics as assessed by the wearable device(s).

    Time frame: From enrollment to end of study period at 14 days

  10. Energy consumption

    Energy consumption as assessed by the wearable device(s).

    Time frame: From enrollment to end of study period at 14 days

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07804927
Lead sponsor
Minneapolis Heart Institute Foundation
Responsible party
Sponsor
First posted
Sep 4, 2026
Start date
Oct 4, 2023
Primary completion
Oct 4, 2027 (estimated)
Completion
Oct 4, 2027 (estimated)
Last update
Sep 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion